February 20, 2020

Magenta Therapeutics

Magenta Therapeutics Announces Updated Phase 2 Data on MGTA-456 Cell Therapy, Demonstrating Continued Durability in Inherited Metabolic Disorders

February 20, 2020


GBT Accepting Proposals for 2020 ACCEL Grants to Support Novel Access-to-Care Programs for People Living with Sickle Cell Disease

February 18, 2020


Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

February 18, 2020

bluebird bio

bluebird bio Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Operational Progress

February 13, 2020

Foundation Medicine

Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan

Load More

Sign up for weekly portfolio news.